medigraphic.com
ISSN 2007-8560 (Impreso)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2008, Número 2

<< Anterior Siguiente >>

Ortho-tips 2008; 4 (2)


Tumores óseos benignos de comportamiento agresivo

Moreno HLF, Moreno WE, Ramírez VSO, Tecualt GR, Amaya ZRA, Morfín PA

Idioma: Español
Referencias bibliográficas: 44
Paginas: 111-127
Archivo PDF: 675.70 Kb.


FRAGMENTO

Los tumores benignos de comportamiento agresivo fueron clasificados en 1980 por el Dr. William Fisher Enneking y se caracterizan por ser muy sintomáticos, de crecimiento rápido, por romper la cortical y hacerse extracompartimentales en muy poco tiempo. Histológicamente son benignos, aunque pueden desarrollar metástasis pulmonares múltiples, en particular el tumor de células gigantes, que se clasifica como etapa 3 de Enneking.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop Relat Res 2003; (415): 4-18.

  2. Jaffe HL, Lichtenstein L. Chondromyxoid fibroma of bone: a distinctive benign tumour likely to be mistaken for chondrosarcoma. Arch Pathol 1948; 45: 541-51.

  3. Merine D, Fishman EK, Rosengard A, Tolo V. Chondromyxoid fibroma of the fibula. J Pediatr Orthop 1989; 9(4): 468-71.

  4. Safar A, Nelson M, Neff JR, Maale GE, Bayani J, Squire J, Bridge JA. Recurrent anomalies of 6q25 in Chondromyxoid fibroma. Hum Pathol 2000; 31(3): 306-11.

  5. Armah HB, McGough RL, Goodman MA, Gollin SM, Surti U, Parwani AV, Rao UN. Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites. Diagn Pathol 2007; 2: 44.

  6. Merine D, Fishman EK, Rosengard A, Tolo V. Chondromyxoid fibroma of the fibula. J Pediatr Orthop 1989; 9(4): 468-71.

  7. Daghfous M, Charfi H, Turki M, Maalla R, Baccari S, Tarhouni L. Chondromyxoid fibroma. A case report of location in the phalanx of the thumb. Chir Main 2007; 26(3): 159-64.

  8. Ebrahimzadeh MH, Dallouei SR. Chondromyxoid fibroma of the calcaneous. J Am Podiatr Med Assoc 2007; 97(3): 223-4.

  9. Ayadi-Kaddour A, Saïji E, Fénniche S, Braham E, Ismail O, Djilani H, El Mezni F. Costal chondromyxoid fibroma. Rev Chir Orthop Reparatrice Appar Mot 2007; 93(1): 84-7.

  10. Ralph LL. Chondromyxoid Fibroma of bone. J Bone Joint Surg Br 1962; 44-B: 7-24.

  11. Rahimi A, Beabout JW, Ivins JC, Dahlin DC. Chondromyxoid fibroma: a Clinicopathologic study of 76 cases. Cancer 1972; 30(3): 726-36.

  12. Springfield DS, Capanna R, Gherlinzoni F, Picci P, Campanacci M. Chondroblastoma. A review of seventy cases. J Bone Joint Surg Am 1985; 67: 748-755.

  13. Ramappa AJ, Lee FYI, Tang P, Carlson JR, Gebhardt MC, Mankin HJ. Chondroblastoma of bone. J Bone Joint Surg Am 2000; 82: 1140.

  14. Turcotte RE, Kurt AM, Sim FH, Unni KK, McLeod RA. Chondroblastoma. Hum Pathol 1993; 24(9): 944-9.

  15. Kunkel MG, Dahlin DC, Young HH. Benign chondroblastoma. J Bone Joint Surg Am 1956; 38: 817-826.

  16. Monda L, Wick MR. S-100 protein immunostaining in the differential diagnosis of chondroblastoma. Hum Pathol 1985; 16(3): 287-93.

  17. Huvos AG, Marcove RC. Chondroblastoma of bone. A critical review. Clin Orthop Relat Res 1973; (95): 300-12.

  18. Suneja R, Grimer RJ, Belthur M, Jeys L, Carter SR, Tillman RM, Davies AM. Chondroblastoma of bone: long-term results and functional outcome after intralesional curettage. J Bone Joint Surg Br 2005; 87-B: 974-978.

  19. Wirman JA, Crissman JD, Aron BF. Metastatic chondroblastoma: report of an unusual case treated with radiotherapy. Cancer 1979; 44(1): 87-93.

  20. Swarts SJ, Neff JR, Johansson SL, Nelson M, Bridge JA. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res 1998; (349): 189-93.

  21. Bandyopadhyay A, Chakraborty J, Choudhuri MK, Guha D, Mallick MG, Roy S, Mitra K. Recurrent and aggressive chondroblastoma: a case report. Indian J Pathol Microbiol 2007; 50(4): 780-2.

  22. Unni K. Dahlin´s Bone tumours; General aspects and data on 11087 cases. Philadelphia: Lippincott- Raven, 1998.

  23. Carrasco CH, Murriay JA. Giant-Cell Tumors. Orthop Clin North Am 1989; 20: 395-405.

  24. Dahlin DC. Giant-cell tumor of vertebrae above the sacrum. A review of 31 cases. Cancer 1977; 39: 1350-1356.

  25. Larson SW, Boquist LR. Giant-cell tumors of the spine and sacrum causing neurological symptoms. Clin Orthop 1975; 111: 201-211.

  26. Hermman SD, Mesgarzade M, Bonakdarpour A, Dalinka MK. The role of magnetic resonance imaging in Giant cell tumor to bone. Skeletal Radiol 1987; 16: 635-643.

  27. Tarkkanen M, Kaipainen A, Karaharju E, Böhling T, Szymanska J, Heliö H, Kivioja A, Elomaa I, Knuutila S. Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet 1993; 68(1): 1-21.

  28. Lukeis R, Ball D, Irving L, Garson OM, Hasthorpe S. Chromosome abnormalities in non-small cell lung cancer pleural effusions: cytogenetic indicators of disease subgroups. Genes Chromosomes Cancer 1993; 8(4): 262-9.

  29. Rock ME, Simm FH, Unni KK, Witrak GA, Frassika FJ, Schray MF, et al. Secondary malignant Giant cell tumor of bone, clinicopathological assessment of nineteen patients. J Bone Join Surg Am 1986; 68: 1073-1079.

  30. Toy PC, France J, Randall RL, Neel MD, Shorr RI, Heck RK. Reconstruction of noncontained distal femoral defects with polymethylmethacrylate and crossed-screw augmentation: a biomechanical study. J Bone Joint Surg Am. 2006; 88(1): 171-8.

  31. Moreno WE, Moreno HLF, Tecualt GR, Morfín PA, Padilla LR, Roji AC, Amaya ZRA. Utilidad del polimetilmetacrilato en el tumor de células gigantes óseo. Acta Ortopédica Mexicana 2003; 17(6): 281-286.

  32. Muscolo DL, Ayerza MA, Calabrese ME, Gruenberg M. The use of a bone allograft for reconstruction after resection of giant-cell tumor close to the knee. J Bone Joint Surg Am 1993; 75: 1656-1662.

  33. Jeffrey BF, Moran SL, Bishop AT, Wood CM, Shin FAY. Vascularized fibular graft salvage of complications of long-bone allograft after tumor reconstruction. J Bone Joint Surg Am 2008; 90: 93-100.

  34. Biau D, Faure F, Katsahian S, Jeanrot C, Tomeno B, Anract P. Survival of total knee replacement with a megaprosthesis after bone tumor resection. J Bone Joint Surg Am 2006; 88(6): 1285-93.

  35. Ilyas I, Kurar A, Moreau PG, Younge DA. Modular megaprosthesis for distal femoral tumors. Int Orthop 2001; 25(6): 375-7.

  36. Moreno HLF, Ramírez VA, Tecualt GR. Tratamiento de los tumores óseos de la rodilla con cirugía amplia y prótesis no convencional. Rev Mex Ortop Traum 1995 9(5): 282-289.

  37. Chim H, Tan BK, Tan MH, Tan KC, Song C. Optimizing the use of local muscle flaps for knee megaprosthesis coverage. Ann Plast Surg 2007; 59(4): 398-403.

  38. Moreno HLF, Ramírez VA, Tecualt GR. Tumores agresivos de la rodilla. Tratamiento con cirugía amplia y clavo centromedular. Rev Mex Ortop Traum 1995; 9(5): 282-289.

  39. Althausen PL, Schneider PD, Bold RJ, Gupta MC, Goodnight JE Jr, Khatri VP. Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine 2002; 27(15): E361-5.

  40. Nair MK, Jyothirmayi R. Radiation therapy in the treatment of giant cell tumor of bone. Int J Radiat Oncol Biol Phys 1999; 43: 1065-1069.

  41. Hefti FL, Gachter A, Remagen W, Nidecker A. Recurrent giant-cell tumor with metaplasia and malignant change, not associated with radiotherapy. A case report. J Bone Joint Surg Am 1992; 74: 930-934.

  42. Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: a clinicopathologic study of prognostic factors. Pathol Int 1998; 48: 723-729.

  43. Bertoni F, Present D, Enneking WF. Giant-cell tumor of bone with pulmonary metastases. J Bone Joint Surg Am 1985; 67: 890-900.

  44. Siebenrock KA, Unni KK, Rock MG. Giant-cell tumour of bone metastasing to the lungs: a long-term follow-up. J Bone Joint Surg Br 1998; 80-B: 43-47.




2020     |     www.medigraphic.com